Tag

UF Innovate | Sid Martin Biotech

AGTC Announces Expansion of Manufacturing and Analytics Capabilities to Advance Commercialization of Gene Therapy Product Candidates

UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced that it has initiated plans to lease a build-to-suit 21,000 square foot current Good Manufacturing Practices (cGMP) manufacturing and quality control facility adjacent to its Florida facility to prepare for anticipated late-stage development of its X-Linked Retinitis Pigmentosa (XLRP) and Achromatopsia (ACHM) programs.

UF Innovate Names New Director of Incubation Services

UF Innovate is pleased to welcome Karl R. LaPan as the incoming director of incubation services. He will join the team May 3 and work alongside current Director Mark S. Long, who will retire this summer. LaPan comes to the position with more than 20 years of experience in business incubation.

Florida High Tech Corridor Incubators Experience Startup Surge

Florida native and CEO of Agriculture Intelligence Matt Donovan has discovered a “renewed environment with a fertile ground for talent.” A resident company in UF Innovate | The Hub, Agriculture Intelligence is a precision agriculture science company combining machine vision, machine learning and artificial intelligence to provide cloud-based, precision data for specialty crops.

Breakthrough Paper Outlines Path to Heart Regeneration After Cardiac Injury

Cardiovascular disease kills more than 650,000 Americans annually. Those who survive myocardial infarction remain at risk of death because the human heart has a very limited ability to repair itself. No one has yet found a method that leads to cardiovascular regeneration for a damaged human heart. But all that may change thanks to a revolutionary medical paper written by Dr. Ian White, president and CSO of UF Innovate | Sid Martin Biotech resident Neobiosis, a company that focuses on the science of regenerative medicine.

AGTC Licenses Promoter Technology to SparingVision SAS

UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced a licensing agreement that provides its proprietary cone-specific promoter technology to SparingVision SAS, a genomic medicine company developing vision-saving treatments for ocular diseases.